Pacira Pharmaceuticals (PCRX) PT Lowered to $36 at Goldman Sachs

February 16, 2018 7:05 AM EST Send to a Friend

Goldman Sachs lowered its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Pacira Pharmaceuticals (PCRX) PT Lowered to $36 at Goldman Sachs

Member Login

Free News Feed